246 related articles for article (PubMed ID: 16883377)
1. Prevalence of illicit drug use in patients without controlled substance abuse in interventional pain management.
Manchikanti L; Pampati V; Damron KS; Beyer CD; Barnhill RC
Pain Physician; 2003 Apr; 6(2):173-8. PubMed ID: 16883377
[TBL] [Abstract][Full Text] [Related]
2. A comparative evaluation of illicit drug use in patients with or without controlled substance abuse in interventional pain management.
Manchikanti L; Damron KS; Beyer CD; Pampati V
Pain Physician; 2003 Jul; 6(3):281-5. PubMed ID: 16880872
[TBL] [Abstract][Full Text] [Related]
3. Controlled substance abuse and illicit drug use in chronic pain patients: An evaluation of multiple variables.
Manchikanti L; Cash KA; Damron KS; Manchukonda R; Pampati V; McManus CD
Pain Physician; 2006 Jul; 9(3):215-25. PubMed ID: 16886030
[TBL] [Abstract][Full Text] [Related]
4. Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids?
Manchikanti L; Manchukonda R; Pampati V; Damron KS; Brandon DE; Cash KA; McManus CD
Pain Physician; 2006 Apr; 9(2):123-9. PubMed ID: 16703972
[TBL] [Abstract][Full Text] [Related]
5. National All Schedules Prescription Electronic Reporting Act (NASPER): balancing substance abuse and medical necessity.
Manchikanti L; Brown KR; Singh V
Pain Physician; 2002 Jul; 5(3):294-319. PubMed ID: 16902657
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of variables in illicit drug use: does a controlled substance abuse screening tool identify illicit drug use?
Manchikanti L; Pampati V; Damron KS; McManus CD
Pain Physician; 2004 Jan; 7(1):71-5. PubMed ID: 16868615
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of abuse of prescription and illicit drugs in chronic pain patients receiving short-acting (hydrocodone) or long-acting (methadone) opioids.
Manchikanti L; Manchukonda R; Pampati V; Damron KS
Pain Physician; 2005 Jul; 8(3):257-61. PubMed ID: 16850081
[TBL] [Abstract][Full Text] [Related]
8. Patterns of illicit drug use and opioid abuse in patients with chronic pain at initial evaluation: a prospective, observational study.
Manchikanti L; Damron KS; McManus CD; Barnhill RC
Pain Physician; 2004 Oct; 7(4):431-7. PubMed ID: 16858484
[TBL] [Abstract][Full Text] [Related]
9. National drug control policy and prescription drug abuse: facts and fallacies.
Manchikanti L
Pain Physician; 2007 May; 10(3):399-424. PubMed ID: 17525776
[TBL] [Abstract][Full Text] [Related]
10. Does adherence monitoring reduce controlled substance abuse in chronic pain patients?
Manchikanti L; Manchukonda R; Damron KS; Brandon D; McManus CD; Cash K
Pain Physician; 2006 Jan; 9(1):57-60. PubMed ID: 16700282
[TBL] [Abstract][Full Text] [Related]
11. Marijuana correlates with use of other illicit drugs in a pain patient population.
Pesce A; West C; Rosenthal M; West R; Crews B; Mikel C; Almazan P; Latyshev S; Horn PS
Pain Physician; 2010; 13(3):283-7. PubMed ID: 20495593
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of patients with increasing opiate needs: prescription opiate abuse and illicit drug use.
Manchikanti L; Damron KS; Pampati V; McManus CD
Pain Physician; 2004 Jul; 7(3):339-44. PubMed ID: 16858472
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of illicit drug use among individuals with chronic pain in the Commonwealth of Kentucky: an evaluation of patterns and trends.
Manchikanti L; Fellows B; Damron KS; Pampati V; McManus CD
J Ky Med Assoc; 2005 Feb; 103(2):55-62. PubMed ID: 15751456
[TBL] [Abstract][Full Text] [Related]
14. Screening for controlled substance abuse in interventional pain management settings: evaluation of an assessment tool.
Manchikanti L; Singh V; Damron KS; Beyer CD; Pampati V
Pain Physician; 2003 Oct; 6(4):425-33. PubMed ID: 16871293
[TBL] [Abstract][Full Text] [Related]
15. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids.
Manchikanti L; Singh A
Pain Physician; 2008 Mar; 11(2 Suppl):S63-88. PubMed ID: 18443641
[TBL] [Abstract][Full Text] [Related]
17. Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history.
Michna E; Ross EL; Hynes WL; Nedeljkovic SS; Soumekh S; Janfaza D; Palombi D; Jamison RN
J Pain Symptom Manage; 2004 Sep; 28(3):250-8. PubMed ID: 15336337
[TBL] [Abstract][Full Text] [Related]
18. Dental care of patients with substance abuse.
Bullock K
Dent Clin North Am; 1999 Jul; 43(3):513-26. PubMed ID: 10516924
[TBL] [Abstract][Full Text] [Related]
19. Community-wide estimation of illicit drug use in delivering women: prevalence, demographics, and associated risk factors.
Vaughn AJ; Carzoli RP; Sanchez-Ramos L; Murphy S; Khan N; Chiu T
Obstet Gynecol; 1993 Jul; 82(1):92-6. PubMed ID: 8515933
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of opioid abuse in interventional pain medicine practice settings: a randomized clinical evaluation.
Manchikanti L; Pampati V; Damron KS; Fellows B; Barnhill RC; Beyer CD
Pain Physician; 2001 Oct; 4(4):358-65. PubMed ID: 16902682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
